90TEN scoops Communiqué Communications Consultancy of the Year Award for the Second Year Running

www.90ten.co.uk.

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision®) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.

Envision has 14 offices: six in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London (Battersea and Hammersmith), and Wilmslow; one in Serbia – Subotica; one in Hungary – Szeged; four in the United States – Fairfield and Glastonbury, CT, Philadelphia, PA, Warren, NJ; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs around 800 team members, including over 250 highly qualified and experienced in-house medical writers, and 190 technology solutions team members who provide software development and customer support. To find out more, visit www.envisionpharmagroup.com.

 

90TEN named EMEA Healthcare Consultancy of the Year at 2020 EMEA SABRE awards

www.90ten.co.uk.

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision®) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.

Envision has 14 offices: six in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London (Battersea and Hammersmith), and Wilmslow; one in Serbia – Subotica; one in Hungary – Szeged; four in the United States – Fairfield and Glastonbury, CT, Philadelphia, PA, Warren, NJ; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs around 800 team members, including over 250 highly qualified and experienced in-house medical writers, and 190 technology solutions team members who provide software development and customer support. To find out more, visit www.envisionpharmagroup.com.

– ends –

 

90TEN named Best Agency in Continental Europe at PRWeek Global Awards

Paul Tanner, Chairman of 90TEN, clearly delighted with our newly-won awards

“The consultancy award is a tremendous honour and comes after an incredible year for 90TEN, which saw us expand our client portfolio and team, with 30 new hires,” said Paul Tanner, Chairman. “We strive to deliver work that doesn’t just change what people see, hear and read, but what they feel, think and do. This award is a testament to our passionate team who partner with our clients to deliver campaigns that truly make a difference.”

The judges described 90TEN as: “Disrupting healthcare comms with innovation, smart thinking and what looks like fun! Refreshing self-awareness”.

90TEN’s Flight HIV101 campaign, on behalf of Gilead, aimed to help gay men living with HIV discuss long-term health with their doctor. Close community collaboration meant that it was a campaign developed by gay men for gay men. It centred around a flight safety comedy short featuring HIV-positive drag queen Panti Bliss. The campaign reached 29 million people across six countries, with 22% of the target population taking steps to improve their future health.

90TEN was also a finalist in the Healthcare category for its campaign with Ferring Pharmaceuticals entitled ‘Project Family’. The campaign champions everyone’s right to have a family and tackles maternal health issues.

The PRWeek Global Awards honour the best examples of behaviour change and organisational growth across both the consumer and healthcare communications industries globally. The submissions are judged by a panel of industry experts and leaders.